Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MYELOID LEUKEMIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 7169 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Van Limbergen, H; Poppe, B; Michaux, L; Herens, C; Brown, J; Noens, L; Berneman, Z; De Bock, R; De Paepe, A; Speleman, F
      Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH

      GENES CHROMOSOMES & CANCER
    2. Maserati, E; Aprili, F; Vinante, F; Locatelli, F; Amendola, G; Zatterale, A; Milone, G; Minelli, A; Bernardi, F; Lo Curto, F; Pasquali, F
      Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20%of cases

      GENES CHROMOSOMES & CANCER
    3. Foss, B; Ulvestad, E; Hervig, T; Bruserud, O
      Effects of cytarabine and various anthracyclins on platelet activation: Characterization of in vitro effects and their possible clinical relevance inacute myelogenous leukemia

      INTERNATIONAL JOURNAL OF CANCER
    4. Bruserud, O
      Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia

      INTERNATIONAL IMMUNOPHARMACOLOGY
    5. Druker, BJ
      Current treatment approaches for chronic myelogenous leukemia

      CANCER JOURNAL
    6. Porter, DL
      The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic stem cell transplantation

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    7. Marijt, WAF; Falkenburg, JHF
      Specific T cell therapy in leukemia

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    8. Maki, G
      Ex vivo purging of stem cell autografts using cytotoxic cells

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    9. Godder, KT; Henslee-Downey, PJ
      Colony-stimulating factors in stem cell transplantation: Effect on qualityof life

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    10. Borbolla, JR; Najera, A; Arana, RM; Lopez-Hernandez, MA; Mendoza, Y; Trueba, E
      In vivo purging of peripheral blood stem cells obtained by apheresis, using high-dose chemotherapy and granulocyte colony-stimulating factor in chronic myelogenous leukemia patients

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    11. Hu, XT; Zuckerman, KS
      Transforming growth factor: signal transduction pathways, cell cycle mediation, and effects on hematopoiesis

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    12. Foss, B; Mentzoni, L; Bruserud, O
      Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    13. Muller, L; Provenzani, C; Pawelec, G
      Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell cultures

      JOURNAL OF IMMUNOTHERAPY
    14. Morecki, S; Yacovlev, E; Gelfand, Y; Uzi, I; Slavin, S
      Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma

      JOURNAL OF IMMUNOTHERAPY
    15. Goh, M; Chen, F; Paulsen, MT; Yeager, AM; Dyer, ES; Ljungman, M
      Phenylbutyrate attenuates the expression of Bcl-X-L, DNA-PK, caveolin-1, and VEGF in prostate cancer cells

      NEOPLASIA
    16. Bain, BJ
      Cytogenetics in haematology - Overview

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    17. Olney, HJ; Le Beau, MM
      The cytogenetics of myelodysplastic syndromes

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    18. Harrison, CJ
      Acute lymphoblastic leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    19. Kearney, L
      Molecular cytogenetics

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    20. Dann, EJ; Rowe, JM
      Biology and therapy of secondary leukaemias

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    21. Torelli, GF; Orsini, E; Guarini, A; Kell, J; Foa, R
      Developmental approaches in immunological control of acute myelogenous leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    22. Hall, PD; Virella, G; Willoughby, T; Atchley, DH; Kreitman, RJ; Frankel, AE
      Antibody response to DT-GM, a novel fusion toxin consisting of a truncateddiphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia

      CLINICAL IMMUNOLOGY
    23. Pawelec, G; Muller, L; Wagner, W
      MHC class II-restricted tumor antigens and CD4(+) T cells play a role in hematological malignancies as well as solid tumors

      TRENDS IN IMMUNOLOGY
    24. Wang, RF
      MHC class II-restricted tumor antigens and CD4(+) T cells play a role in hematological malignancies as well as solid tumors - Response

      TRENDS IN IMMUNOLOGY
    25. Campbell, JDM; Cook, G; Holyoake, TL
      Evolution of bone marrow transplantation - the original immunotherapy

      TRENDS IN IMMUNOLOGY
    26. Agarwala, SS; Sabbagh, MH
      Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment

      EXPERT OPINION ON BIOLOGICAL THERAPY
    27. Rousseau, RF; Bollard, CM; Heslop, HE
      Gene therapy for paediatric leukaemia

      EXPERT OPINION ON BIOLOGICAL THERAPY
    28. Nawrocki, S; Wysocki, PJ; Mackiewicz, A
      Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer

      EXPERT OPINION ON BIOLOGICAL THERAPY
    29. Bhatia, V; Porter, DL
      Novel approaches to allogeneic stem cell therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    30. Joberty, G; Perlungher, RR; Sheffield, PJ; Kinoshita, M; Noda, M; Haystead, T; Macara, IG
      Borg proteins control septin organization and are negatively regulated by Cdc42

      NATURE CELL BIOLOGY
    31. Dietz, AB; Litzow, MR; Bulur, PA; Vuk-Pavlovic, S
      Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells

      CYTOTHERAPY
    32. Mardlin, P; Chessells, JM
      Childhood leukaemia: the medical cost of cure

      HOSPITAL MEDICINE
    33. Grigg, A; Kannan, K; Schwarer, AP; Spencer, A; Szer, J
      Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation

      INTERNAL MEDICINE JOURNAL
    34. Litman, T; Druley, TE; Stein, WD; Bates, SE
      From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance

      CELLULAR AND MOLECULAR LIFE SCIENCES
    35. Marmorstein, R
      Structure and function of histone acetyltransferases

      CELLULAR AND MOLECULAR LIFE SCIENCES
    36. Graessle, S; Loidl, P; Brosch, G
      Histone acetylation: plants and fungi as model systems for the investigation of histone deacetylases

      CELLULAR AND MOLECULAR LIFE SCIENCES
    37. Timmermann, S; Lehrmann, H; Polesskaya, A; Harel-Bellan, A
      Histone acetylation and disease

      CELLULAR AND MOLECULAR LIFE SCIENCES
    38. Maru, Y; Bergmann, E; Coin, F; Egly, JM; Shibuya, M
      TFIIH functions are altered by the P210BCR-ABL oncoprotein produced on thePhiladelphia chromosome

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    39. Giver, CR; Wong, R; Moore, DH; Pallavicini, MG
      Persistence of aneuploid immature/primitive hemopoietic sub-populations inmice 8 months after benzene exposure in vivo

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    40. Lothstein, L; Israel, M; Sweatman, TW
      Anthracycline drug targeting: cytoplasmic versus nuclear - a fork in the road

      DRUG RESISTANCE UPDATES
    41. Radojkovic, M; Ristic, S; Colovic, M; Todoric, B; Krtolica, K
      Busulfan-induced loss of Ph chromosome in chronic myeloid leukemia

      MEDICAL ONCOLOGY
    42. Krishnan, N; Buckley, DJ; Zhang, MY; Reed, JC; Buckley, AR
      Prolactin-stimulated X-linked inhibitor of apoptosis protein expression during S phase cell cycle progression in rat Nb2 lymphoma cells

      ENDOCRINE
    43. Grande, A; Montanari, M; Manfredini, R; Tagliafico, E; Zanocco-Marani, T; Trevisan, F; Ligabue, G; Siena, M; Ferrari, S; Ferrari, S
      A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines

      CELL DEATH AND DIFFERENTIATION
    44. Farmaki, E; Roilides, E
      Immunotherapy in patients with systemic mycoses - A promising adjunct

      BIODRUGS
    45. Bruserud, O; Foss, B; Petersen, H
      Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L)

      EUROPEAN CYTOKINE NETWORK
    46. Freeburn, RW; Kendall, H; Dobson, L; Egan, J; Simler, NJ; Millar, AB
      The 3 ' untranslated region of tumor necrosis factor-alpha is highly conserved in idiopathic pulmonary fibrosis

      EUROPEAN CYTOKINE NETWORK
    47. Heisterkamp, N; Voncken, JW; Senadheera, D; Hemmeryckx, B; Gonzalez-Gomez, I; Reichert, A; Pattengale, PK; Groffen, J
      The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    48. Wang, CG; Fu, MF; Mani, S; Wadler, S; Senderowicz, AM; Pestell, RG
      Histone acetylation and the cell-cycle in cancer

      FRONTIERS IN BIOSCIENCE
    49. Filetici, P; Ornaghi, P; Ballario, P
      The bromodomain: A chromatin browser?

      FRONTIERS IN BIOSCIENCE
    50. Thomas, JG; Olson, JM; Tapscott, SJ; Zhao, LP
      An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles

      GENOME RESEARCH
    51. Benthin, M; Dallmann, I; Atzpodien, J
      13cis-and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatmentin vitro

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    52. Bagg, A
      Minimal residual disease: How low do we go?

      MOLECULAR DIAGNOSIS
    53. Khoury, H; Adkins, D; Brown, R; Pence, H; Vij, R; Goodnough, LT; Westervelt, P; Trinkaus, K; Lin, HS; DiPersio, J
      Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    54. Patterson, AE; Korngold, R
      Infusion of select leukemia-reactive TCR V beta(+) T cells provides graft-versus leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    55. Alvarnas, JC; Linn, YC; Hope, EG; Negrin, RS
      Expansion of cytotoxic CD3(+)CD56(+) cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    56. Porter, DL; Luger, SM; Duffy, KM; Stadtmauer, EA; Laport, G; Schuster, SJ; Orloff, G; Tsai, D; McDaid, K; Kathakali, A; Leonard, DGB; Antin, JH
      Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    57. Johnson, BD; Dagher, N; Stankowski, MC; Hanke, CA; Truitt, RL
      Donor natural killer (NK1.1(+)) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    58. Dey, BR; McAfee, S; Sackstein, R; Colby, C; Saidman, S; Weymouth, D; Poliquin, C; Vanderklish, J; Sachs, DH; Sykes, M; Spitzer, TR
      Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    59. Shimoni, A; Gajewski, J; Donato, M; Martin, T; O'Brien, S; Talpaz, M; Cohen, A; Korbling, M; Champlin, R; Giralt, S
      Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    60. Kummar, S; Ishii, A; Yang, HK; Venzon, DJ; Kim, SJ; Gress, RE
      Modulation of graft-versus-tumor effects in a murine allogeneic bone marrow transplantation model by tumor-derived transforming growth factor-beta 1

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    61. Carlens, S; Remberger, M; Aschan, J; Ringden, O
      The role of disease stage in the response to donor lymphocyte infusions astreatment for leukemic relapse

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    62. Bartolo, C; Viswanatha, DS
      Molecular methods for minimal residual disease detection in hematolymphoiddiseases: Principles and applications

      JOURNAL OF CLINICAL LIGAND ASSAY
    63. Richon, VM; Zhou, XB; Rifkind, RA; Marks, PA
      Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers

      BLOOD CELLS MOLECULES AND DISEASES
    64. Honda, H; Hirai, H
      Model mice for BCR/ABL-positive leukemias

      BLOOD CELLS MOLECULES AND DISEASES
    65. Dazzi, F; Simpson, E; Goldman, JM
      Minor antigen solves major problem

      NATURE MEDICINE
    66. Hiebert, S
      Differentiation or leukemia: Is C/EBP alpha the answer?

      NATURE MEDICINE
    67. Vigneri, P; Wang, JYJ
      Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase

      NATURE MEDICINE
    68. Dent, P; Grant, S
      Pharmacologic interruption of the mitogen-activated extracellular-regulated kinase/mitogen-activated protein kinase signal transduction pathway: Potential role in promoting cytotoxic drug action

      CLINICAL CANCER RESEARCH
    69. Ferrajoli, A; Manshouri, T; Estrov, Z; Keating, MJ; O'Brien, S; Lerner, S; Beran, M; Kantarjian, HM; Freireich, EJ; Albitar, M
      High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia

      CLINICAL CANCER RESEARCH
    70. Narla, RK; Dong, YH; Klis, D; Uckun, FM
      Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity

      CLINICAL CANCER RESEARCH
    71. Gaiger, A; Carter, L; Greinix, H; Carter, D; McNeill, PD; Houghton, RL; Cornellison, CD; Vedvick, TS; Skeiky, YAW; Cheever, MA
      WT1-specific serum antibodies in patients with leukemia

      CLINICAL CANCER RESEARCH
    72. Gilliland, DG
      The diverse role of the ETS family of transcription factors in cancer - Commentary re: B. Davidson, Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin. Cancer Res., 7 : 551-557, 2001.

      CLINICAL CANCER RESEARCH
    73. Koomagi, R; Zintl, F; Sauerbrey, A; Volm, M
      Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction

      CLINICAL CANCER RESEARCH
    74. Ohno, N; Tani, A; Chen, ZS; Uozumi, K; Hanada, S; Akiba, S; Ren, XQ; Furukawa, T; Sumizawa, T; Arima, T; Akiyama, S
      Prognostic significance of multidrug resistance protein in adult T-cell leukemia

      CLINICAL CANCER RESEARCH
    75. Banerjee, A; Shannon, KM
      Leukemic transformation in patients with severe congenital neutropenia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    76. Taub, JW
      Relationship of chromosome 21 and acute leukemia in children with Down syndrome

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    77. Mhawech, P; Buffone, GJ; Khan, SP; Gresik, MV
      Cytochemical staining and flow cytometry methods applied to the diagnosis of acute leukemia in the pediatric population: An assessment of relative usefulness

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    78. Shearer, P; Kapoor, G; Beckwith, JB; Takashima, J; Breslow, N; Green, DM
      Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: A report from the National Wilms Tumor Study Group

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    79. Monteleone, PM; Steele, DA; King, AK; Konefal, S; Kelleher, JF
      Bilateral breast relapse in acute myelogenous leukemia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    80. Aquino, VM; Schneider, NR; Sandler, ES
      Secondary myelodysplasia with monosomy 7 arising after treatment for acutelymphoblastic leukemia in childhood

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    81. Weiskopf, AS; Vouros, P; Cunniff, J; Binderup, E; Bjorkling, F; Binderup, L; White, MC; Posner, GH
      Examination of structurally selective derivatization of vitamin D-3 analogues by electrospray mass spectrometry

      JOURNAL OF MASS SPECTROMETRY
    82. Rudolph, MJ; Gergen, JP
      DNA-binding by Ig-fold proteins

      NATURE STRUCTURAL BIOLOGY
    83. Bravo, J; Li, Z; Speck, NA; Warren, AJ
      The leukemia-associated AML1 (Runx1)-CBF beta complex functions as a DNA-induced molecular clamp

      NATURE STRUCTURAL BIOLOGY
    84. Farese, AM; Casey, DB; Smith, WG; Vigneulle, RM; McKearn, JP; MacVittie, TJ
      Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: Effect of schedule, dose, and route of administration

      STEM CELLS
    85. Dialynas, DP; Shao, LE; Billman, GF; Yu, J
      Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood

      STEM CELLS
    86. Karlic, H; Louda, N; Pfeilstocker, M; Keil, F; Lohninger, A; Pittermann, E; Paukovits, J
      Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1 alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML)

      STEM CELLS
    87. Farese, AM; Smith, WG; Giri, JG; Siegel, N; McKearn, JP; MacVittie, TJ
      Promegapoietin-1a, an engineered chimeric IL-3 and Mpl-L receptor agonist,stimulates hematopoietic recovery in conventional and abbreviated schedules following radiation-induced myelosuppression in nonhuman primates

      STEM CELLS
    88. Janowska-Wieczorek, A; Majka, M; Ratajczak, J; Ratajczak, MZ
      Autocrine/paracrine mechanisms in human hematopoiesis

      STEM CELLS
    89. Cutler, C; Antin, JH
      Peripheral blood stem cells for allogeneic transplantation: A review

      STEM CELLS
    90. Bruserud, O; Gjertsen, BT; Foss, B; Huang, TS
      New strategies in the treatment of acute myelogenous leukemia (AML): In vitro culture of AML cells - The present use in experimental studies and the possible importance for future therapeutic approaches

      STEM CELLS
    91. Anasetti, C; Petersdorf, EW; Martin, PJ; Woolfrey, A; Hansen, JA
      Trends in transplantation of hematopoietic stem cells from unrelated donors

      CURRENT OPINION IN HEMATOLOGY
    92. Feinstein, L; Storb, R
      Reducing transplant toxicity

      CURRENT OPINION IN HEMATOLOGY
    93. Peggs, KS; Mackinnon, S
      Cellular therapy: donor lymphocyte infusion

      CURRENT OPINION IN HEMATOLOGY
    94. Nevo, S; Vogelsang, GB
      Acute bleeding complications in patients after bone marrow transplantation

      CURRENT OPINION IN HEMATOLOGY
    95. Hiebert, SW; Lutterbach, B; Amann, J
      Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins

      CURRENT OPINION IN HEMATOLOGY
    96. Kundu, M; Liu, PP
      Function of the inv(16) fusion gene CBFB-MYH11

      CURRENT OPINION IN HEMATOLOGY
    97. Pollock, JL; Westervelt, P; Walter, MJ; Lane, AA; Ley, TJ
      Mouse models of acute promyelocytic leukemia

      CURRENT OPINION IN HEMATOLOGY
    98. Liedman, D; Zeleznik-Le, N
      Retroviral transduction model of mixed lineage leukemia fused to CREB binding protein

      CURRENT OPINION IN HEMATOLOGY
    99. Van Etten, RA
      Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models

      CURRENT OPINION IN HEMATOLOGY
    100. Gutierrez-Delgado, F; Bensinger, W
      Safety of granulocyte colony-stimulating factor in normal donors

      CURRENT OPINION IN HEMATOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 23:52:44